The Food and Drug Administration has approved an autoinjector that lets patients give themselves a full intravenous-equivalent dose of the most widely used loop diuretic at home, in under 10 seconds.
MannKind Corporation announced the approval of Furoscix ReadyFlow, a furosemide injection given under the skin of the abdomen, for the treatment of edema in adults with heart failure or chronic kidney disease. The company expects it to reach the market by the end of August.
